<p>In this episode Róisin McGuigan (Editor, BioInsights) speaks to Paul Byrne (Senior Director, Genomics, ProtaGene) about the evolution of the gene therapy field, with a specific focus on the complexities posed by biodistribution, vector shedding, and transgene expression in gene therapy development.</p>

In this episode Róisin McGuigan (Editor, BioInsights) speaks to Paul Byrne (Senior Director, Genomics, ProtaGene) about the evolution of the gene therapy field, with a specific focus on the complexities posed by biodistribution, vector shedding, and transgene expression in gene therapy development.

Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

Share Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development

Sign up to save your podcasts

Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development

Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development